Nisa Investment Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.81M | Buy |
|
|||||
|
2025
Q2 | $1.67M | Sell |
|
|||||
|
2025
Q1 | $1.55M | Buy |
|
|||||
|
2024
Q4 | $174K | Sell |
|
|||||
|
2024
Q3 | $155K | Sell |
|
|||||
|
2024
Q2 | $965K | Sell |
|
|||||
|
2024
Q1 | $995K | Sell |
|
|||||
|
2023
Q4 | $3.37M | Buy |
|
|||||
|
2023
Q3 | $2.35M | Sell |
|
|||||
|
2023
Q2 | $2.35M | Sell |
|
|||||
|
2023
Q1 | $2.54M | Buy |
|
|||||
|
2022
Q4 | $2.19M | Buy |
|
|||||
|
2022
Q3 | $88K | Sell |
|
|||||
|
2022
Q2 | $88K | Hold |
|
|||||
|
2022
Q1 | $85K | Sell |
|
|||||
|
2021
Q4 | $2.51M | Buy |
|
|||||
|
2021
Q3 | $392 | Sell |
|
|||||
|
2021
Q2 | $518 | Hold |
|
|||||
|
2021
Q1 | $518 | Sell |
|
|||||
|
2020
Q4 | $611K | Buy |
|
|||||
|
2020
Q3 | $437K | Sell |
|
|||||
|
2020
Q2 | $956K | Sell |
|
|||||
|
2020
Q1 | $1.96M | Buy |
|
|||||
|
2019
Q4 | $2.13M | Buy |
|
|||||
|
2019
Q3 | $565K | Buy |
|
|||||
|
2019
Q2 | $518K | Buy |
|
|||||
|
2019
Q1 | $526K | Buy |
|
|||||
|
2018
Q4 | $400K | Sell |
|
|||||
|
2018
Q3 | $2.41M | Buy |
|
|||||
|
2018
Q2 | $49K | Buy |
|
|||||
|
2018
Q1 | $34K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $51K | Hold |
|
|||||
|
2016
Q2 | $45K | Hold |
|
|||||
|
2016
Q1 | $40K | Buy |
|